January 27, 2024
Neurokappa Therapeutics LLC works with Penn Wharton Venture Acceleration Lab for drug development in the Spring of 2024
December 15, 2023
Neurokappa Therapeutics LLC forms partnership for Quotient Science for business development.
December 2, 2023
Congratulations to Neurokappa Therapeutics for the Third Place for the pitch contest for the technology of dezocine for addiction therapy
at 2023 Wharton Innovation Summit!
October 30, 2023
Congratulations to Professor Gordon Barr (PhD) finished his L-PRINT entrepreneurship program sponsored by NIDA!
Here is his pitch presentation at the conclusion of the program: https://youtu.be/Z7h8AyHNTFQ
September 1, 2023
Dr. Renyu Liu, the founder of Neurokappa Therapeutics, is appointed as a Co-Director at the Penn Psychedelics Collaborative
July 7, 2023
Professor Gordon Barr (PhD) and his proposal to use dezocine to manage opioid crisis are accepted to the L-PRINT entrepreneurship program sponsored by NIDA to be held in Boston in Oct, 2023
Congratulations!
Neurokappa Therapeutics is now a member of PA Life Science!
The team attended and presented in PA life science event
Date: 10/7/2022!
Event Name: Life Sciences Future – BioPharm
Location: Hilton City Ave, Piladelphia, PA
